The Bombay Stock Exchange benchmark Sensex reached a one-month high amid speculation the nation’s central bank may next week halt a record series of interest-rate increases, and on optimism Europe’s debt crisis may ease.
Ranbaxy Laboratories Ltd climbed on a report citing that Chairman Tsutomu Une the drugmaker would start Lipitor sales in the US in November on schedule. Infosys Ltd gained after chief executive officer S D Shibulal said the company’s was not seeing any project cancellations.
Sensex rose 0.6 per cent to 17,165.5 at the close, the highest since August 5. The gauge fluctuated between gains and losses at least 12 times. The S&P CNX Nifty Index on the National Stock Exchange of India advanced 0.6 per cent to 5,153.25, a third day of gain.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
